Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipients

Most CMV-seropositive liver recipients did not develop CMV reactivation, and if reactivations occurred, most were temporal, low-level DNAaemias. Significant CMV infections were successfully treated and recurrences were rare.